Pharma stock to watch: Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY)
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) in the third quarter of FY 17 has reported the adjusted loss per share of $1.06, beating the analysts’ estimates…
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) in the third quarter of FY 17 has reported the adjusted loss per share of $1.06, beating the analysts’ estimates…
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) stock rose over 2.9% on September 11th, 2017 (as of 9:37AM EDT; Source: Google finance) as analysts from Cowen &…